Exploring Cancer Survivor Needs and Preferences for Communicating Personalized Cancer Statistics From Registry Data: Qualitative Multimethod Study.
breast cancer
cancer
cancer registry
cancer statistics
patient needs and preferences
personalization
prostate cancer
risk communication
Journal
JMIR cancer
ISSN: 2369-1999
Titre abrégé: JMIR Cancer
Pays: Canada
ID NLM: 101666844
Informations de publication
Date de publication:
25 Oct 2021
25 Oct 2021
Historique:
received:
10
11
2020
accepted:
25
09
2021
revised:
30
05
2021
entrez:
25
10
2021
pubmed:
26
10
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Disclosure of cancer statistics (eg, survival or incidence rates) based on a representative group of patients can help increase cancer survivors' understanding of their own diagnostic and prognostic situation, and care planning. More recently, there has been an increasing interest in the use of cancer registry data for disclosing and communicating personalized cancer statistics (tailored toward personal and clinical characteristics) to cancer survivors and relatives. The aim of this study was to explore breast cancer (BCa) and prostate cancer (PCa) survivor needs and preferences for disclosing (what) and presenting (how) personalized statistics from a large Dutch population-based data set, the Netherlands Cancer Registry (NCR). To elicit survivor needs and preferences for communicating personalized NCR statistics, we created different (non)interactive tools visualizing hypothetical scenarios and adopted a qualitative multimethod study design. We first conducted 2 focus groups (study 1; n=13) for collecting group data on BCa and PCa survivor needs and preferences, using noninteractive sketches of what a tool for communicating personalized statistics might look like. Based on these insights, we designed a revised interactive tool, which was used to further explore the needs and preferences of another group of cancer survivors during individual think-aloud observations and semistructured interviews (study 2; n=11). All sessions were audio-recorded, transcribed verbatim, analyzed using thematic (focus groups) and content analysis (think-aloud observations), and reported in compliance with qualitative research reporting criteria. In both studies, cancer survivors expressed the need to receive personalized statistics from a representative source, with especially a need for survival and conditional survival rates (ie, survival rate for those who have already survived for a certain period). Personalized statistics adjusted toward personal and clinical factors were deemed more relevant and useful to know than generic or average-based statistics. Participants also needed support for correctly interpreting the personalized statistics and putting them into perspective, for instance by adding contextual or comparative information. Furthermore, while thinking aloud, participants experienced a mix of positive (sense of hope) and negative emotions (feelings of distress) while viewing the personalized survival data. Overall, participants preferred simplicity and conciseness, and the ability to tailor the type of visualization and amount of (detailed) statistical information. The majority of our sample of cancer survivors wanted to receive personalized statistics from the NCR. Given the variation in patient needs and preferences for presenting personalized statistics, designers of similar information tools may consider potential tailoring strategies on multiple levels, as well as effective ways for providing supporting information to make sure that the personalized statistics are properly understood. This is encouraging for cancer registries to address this unmet need, but also for those who are developing or implementing personalized data-driven information tools for patients and relatives.
Sections du résumé
BACKGROUND
BACKGROUND
Disclosure of cancer statistics (eg, survival or incidence rates) based on a representative group of patients can help increase cancer survivors' understanding of their own diagnostic and prognostic situation, and care planning. More recently, there has been an increasing interest in the use of cancer registry data for disclosing and communicating personalized cancer statistics (tailored toward personal and clinical characteristics) to cancer survivors and relatives.
OBJECTIVE
OBJECTIVE
The aim of this study was to explore breast cancer (BCa) and prostate cancer (PCa) survivor needs and preferences for disclosing (what) and presenting (how) personalized statistics from a large Dutch population-based data set, the Netherlands Cancer Registry (NCR).
METHODS
METHODS
To elicit survivor needs and preferences for communicating personalized NCR statistics, we created different (non)interactive tools visualizing hypothetical scenarios and adopted a qualitative multimethod study design. We first conducted 2 focus groups (study 1; n=13) for collecting group data on BCa and PCa survivor needs and preferences, using noninteractive sketches of what a tool for communicating personalized statistics might look like. Based on these insights, we designed a revised interactive tool, which was used to further explore the needs and preferences of another group of cancer survivors during individual think-aloud observations and semistructured interviews (study 2; n=11). All sessions were audio-recorded, transcribed verbatim, analyzed using thematic (focus groups) and content analysis (think-aloud observations), and reported in compliance with qualitative research reporting criteria.
RESULTS
RESULTS
In both studies, cancer survivors expressed the need to receive personalized statistics from a representative source, with especially a need for survival and conditional survival rates (ie, survival rate for those who have already survived for a certain period). Personalized statistics adjusted toward personal and clinical factors were deemed more relevant and useful to know than generic or average-based statistics. Participants also needed support for correctly interpreting the personalized statistics and putting them into perspective, for instance by adding contextual or comparative information. Furthermore, while thinking aloud, participants experienced a mix of positive (sense of hope) and negative emotions (feelings of distress) while viewing the personalized survival data. Overall, participants preferred simplicity and conciseness, and the ability to tailor the type of visualization and amount of (detailed) statistical information.
CONCLUSIONS
CONCLUSIONS
The majority of our sample of cancer survivors wanted to receive personalized statistics from the NCR. Given the variation in patient needs and preferences for presenting personalized statistics, designers of similar information tools may consider potential tailoring strategies on multiple levels, as well as effective ways for providing supporting information to make sure that the personalized statistics are properly understood. This is encouraging for cancer registries to address this unmet need, but also for those who are developing or implementing personalized data-driven information tools for patients and relatives.
Identifiants
pubmed: 34694237
pii: v7i4e25659
doi: 10.2196/25659
pmc: PMC8576563
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e25659Informations de copyright
©Ruben D Vromans, Mies C van Eenbergen, Gijs Geleijnse, Steffen Pauws, Lonneke V van de Poll-Franse, Emiel J Krahmer. Originally published in JMIR Cancer (https://cancer.jmir.org), 25.10.2021.
Références
BMJ. 2017 Nov 6;359:j4891
pubmed: 29109079
Support Care Cancer. 2002 Mar;10(2):161-8
pubmed: 11862506
Breast Cancer Res Treat. 2019 Nov;178(1):1-15
pubmed: 31342311
J Med Internet Res. 2016 Jul 25;18(7):e208
pubmed: 27457709
Nat Rev Drug Discov. 2010 May;9(5):363-6
pubmed: 20431568
Patient Educ Couns. 2008 Dec;73(3):448-55
pubmed: 18755566
Patient Educ Couns. 2017 Mar;100(3):383-410
pubmed: 27765377
Risk Anal. 2009 Feb;29(2):267-87
pubmed: 19000070
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Psychooncology. 2009 Nov;18(11):1199-207
pubmed: 19177461
BMC Med Inform Decis Mak. 2017 Feb 28;17(1):25
pubmed: 28241759
Med Decis Making. 2017 Apr;37(3):179-192
pubmed: 27681991
J Adv Nurs. 2008 Apr;62(1):107-15
pubmed: 18352969
Med Decis Making. 2007 Sep-Oct;27(5):696-713
pubmed: 17873259
Urol Oncol. 2019 Jul;37(7):409-429
pubmed: 31053529
Patient Educ Couns. 2020 Mar;103(3):514-520
pubmed: 31585818
Patient Educ Couns. 2021 Jan;104(1):109-117
pubmed: 32727670
BMJ Open. 2018 Feb 13;8(2):e019171
pubmed: 29440214
Mem Cognit. 1989 Nov;17(6):759-69
pubmed: 2811673
J Clin Oncol. 2005 Feb 20;23(6):1278-88
pubmed: 15718326
Hum Factors. 2017 Jun;59(4):582-627
pubmed: 28192674
Eur J Cancer. 2014 Jul;50(10):1731-1739
pubmed: 24814358
BMC Med Inform Decis Mak. 2020 Oct 27;20(1):277
pubmed: 33109175
J Gen Intern Med. 2013 Sep;28 Suppl 3:S660-5
pubmed: 23797912
Psychol Sci Public Interest. 2007 Nov;8(2):53-96
pubmed: 26161749
Arch Intern Med. 2010 Mar 22;170(6):566-9
pubmed: 20308644
Patient Educ Couns. 2010 Dec;81 Suppl:S87-93
pubmed: 20739135
BMJ. 1995 Jul 29;311(7000):299-302
pubmed: 7633241
Cancer. 2020 Jan 15;126(2):408-415
pubmed: 31580497
Patient Educ Couns. 2020 Oct;103(10):1935-1960
pubmed: 32466864
IEEE Trans Vis Comput Graph. 2017 Jan;23(1):601-610
pubmed: 27875175
Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1645-56
pubmed: 23956026
BMC Med Inform Decis Mak. 2013;13 Suppl 2:S7
pubmed: 24625237
Patient Educ Couns. 2007 Dec;69(1-3):140-4
pubmed: 17942271
Oncology (Williston Park). 2010 May;24(6):521-5
pubmed: 20568593
BMC Med Inform Decis Mak. 2005 Jun 20;5:16
pubmed: 15963238
BMC Med Inform Decis Mak. 2008 Jun 15;8:24
pubmed: 18554419
J Commun. 2012 Oct;62(5):851-868
pubmed: 26405350
Med Decis Making. 2014 May;34(4):443-53
pubmed: 24246564
Drug Ther Bull. 2019 Aug;57(8):119-124
pubmed: 31345957
Palliat Med. 2016 Jul;30(7):661-73
pubmed: 26769733
Patient Educ Couns. 2008 Dec;73(3):443-7
pubmed: 18722073
JMIR Cancer. 2017 Jul 20;3(2):e9
pubmed: 28729232
J Eval Clin Pract. 2006 Feb;12(1):13-23
pubmed: 16422776
J Med Internet Res. 2017 Aug 15;19(8):e288
pubmed: 28811271
Ann Intern Med. 2020 Jun 2;172(11 Suppl):S123-S129
pubmed: 32479176
Int J Environ Res Public Health. 2019 Feb 21;16(4):
pubmed: 30795623
Cochrane Database Syst Rev. 2017 Apr 12;4:CD001431
pubmed: 28402085